StemBright™ Luciferase iPS Cell Pool

Catalog #
78594
$6,125 *
Size: 1 vial
Qty
*US Pricing only. For international pricing, please contact your local distributor.
Purchase
Description

The StemBright™ Luciferase iPS Cell Pool constitutively expresses the firefly luciferase gene under the control of a CMV promoter, introduced via lentiviral transduction (Firefly Luciferase Lentivirus, BPS Bioscience #79692). Luciferase activity can be used to monitor cell viability, both in vitro and in vivo.

Purchase of this cell line is for research purposes only; commercial use requires a separate license. View the full terms and conditions.

Synonyms
iPSC
Product Info
Storage and Usage
Citations
Host Cell Line
Non-Disease Human iPS Cell Line (iXCells 30HU-002)
Supplied As
Each vial contains 2 x 106 cells in 1 ml of iPS cell Freezing Medium
Materials Required But Not Supplied

Media Required for Cell Culture

Name Ordering Information
mTeSR™ Plus Stem Cell Technologies #100-0276
Matrigel™ Corning #354230
DMEM/F12 Thermo Fisher #11330032
Thiazovivin BPS Bioscience #78506
RelesR Stem Cell Technologies #05872
Accutase Thermo Fisher #A1110501
Puromycin Invivogen ant-pr-1

 

Materials Used in the Cellular Assay

Name Ordering Information
ONE-Step™ Luciferase Assay System BPS Bioscience #60690
Luminometer  
Mycoplasma Testing

The cell line has been screened to confirm the absence of Mycoplasma species.

Background

The discovery by Yamanaka and colleagues in 2007 that 4 factors were sufficient to reprogram terminally differentiated fibroblasts into pluripotent stem cells launched the advent of human induced pluripotent stem (iPS) cell technology. These human iPS cells are capable of both self-renewal and differentiation down all three germline lineages and provide both a tool to model human development and disease in the relevant differentiated human cell types, and a unique opportunity for high throughput drug screening.

References
  1. Cao F, et al., 2006 7:1005-1014.
  2. Lepperhof V, et al., 2014 PLoS One. 9(9):
  3. Li X, et al., 2015 Int J Clin Exp Med. 8(6):8938-8947.
  4. Liu Z, et al., 2013 PLoS One. 8(6):
  5. Nishimura, et al., 2022 Methods in Molecular Biology. 2524:291–297.
  6. Takahashi K, et al., 2007 131(5):861–872.